Literature DB >> 28583924

Congenital hypofibrinogenaemia: a presymptomatic detection of an extremely rare bleeding disorder in preterm twins.

Catherine Mary Breen1, Muhammad I Riazat1, Naomi McCallion1, Michael A Boyle1.   

Abstract

Twenty-eight-week-old preterm monochorionic-diamniotic twins were admitted to the neonatal intensive care unit secondary to low birth weight and mild respiratory distress syndrome. A low fibrinogen level of less than 0.5 g/L was detected following an abnormal full blood count. They required fibrinogen transfusions until 32 weeks corrected gestation to maintain adequate fibrinogen levels. Parental screening revealed that their mother had a previously undiagnosed hypofibrinogenaemia. Of note, her only symptom was menorrhagia. This may have implications on further pregnancies as it can be associated with spontaneous miscarriage and post-partum haemorrhage. Congenital hypofibrinogenaemia is a rare disorder and there are no reported cases from Ireland. A higher degree of suspicion for screening is required to detect new cases and demonstrates the benefits of checking parental levels in such situations. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (drugs and medicines); haematology (incl blood transfusion); hydrocephalus; neonatal intensive care

Mesh:

Substances:

Year:  2017        PMID: 28583924      PMCID: PMC5534860          DOI: 10.1136/bcr-2017-219332

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study.

Authors:  S Ahmed; C Harrity; S Johnson; S Varadkar; S McMorrow; R Fanning; C M Flynn; J M O' Riordan; B M Byrne
Journal:  Transfus Med       Date:  2012-10       Impact factor: 2.019

Review 2.  Fibrinogen replacement therapy for congenital fibrinogen deficiency.

Authors:  L Bornikova; F Peyvandi; G Allen; J Bernstein; M J Manco-Johnson
Journal:  J Thromb Haemost       Date:  2011-09       Impact factor: 5.824

Review 3.  Congenital fibrinogen disorders: an update.

Authors:  Philippe de Moerloose; Alessandro Casini; Marguerite Neerman-Arbez
Journal:  Semin Thromb Hemost       Date:  2013-07-12       Impact factor: 4.180

Review 4.  Rare inherited disorders of fibrinogen.

Authors:  S S Acharya; D M Dimichele
Journal:  Haemophilia       Date:  2008-11       Impact factor: 4.287

5.  Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations.

Authors:  C Fenger-Eriksen; M Lindberg-Larsen; A Q Christensen; J Ingerslev; B Sørensen
Journal:  Br J Anaesth       Date:  2008-09-25       Impact factor: 9.166

6.  Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.

Authors:  Manuela Platè; Rosanna Asselta; Silvia Spena; Marta Spreafico; Sharmila Fagoonee; Flora Peyvandi; Maria Luisa Tenchini; Stefano Duga
Journal:  Blood Cells Mol Dis       Date:  2008-08-03       Impact factor: 3.039

  6 in total
  1 in total

Review 1.  Women With Congenital Hypofibrinogenemia/Afibrinogenemia: From Birth to Death.

Authors:  Yan Zhang; Xiaohang Zuo; Yue Teng
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.